Aging-associated skeletal muscle defects in HER2/Neu transgenic mammary tumor model.

These results suggest that breast cancer subtype has a specific impact on the type of molecular and structure changes in skeletal muscle, which needs to be taken into consideration while designing therapies to reduce breast cancer-induced skeletal muscle loss and functional limitations.